Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-amino-1-propanesulfonic Acid
2. 3-aminopropanesulfonic Acid
3. 3-aminopropylsulfonic Acid
4. 3-aps
5. Homotaurine
1. Homotaurine
2. 3-amino-1-propanesulfonic Acid
3. 3687-18-1
4. 3-aminopropane-1-sulfonic Acid
5. 3-aminopropanesulphonic Acid
6. Alzhemed
7. 3aps
8. 1-propanesulfonic Acid, 3-amino-
9. 3-aminopropane Sulfonic Acid
10. 3-aminopropanesulfonic Acid
11. Cerebril
12. Nc-758
13. Tramiprosate [usan]
14. 3-aminopropanesulfonate
15. Nsc-77071
16. Acamprosate Related Compound A
17. 5k8eax0g53
18. Chebi:1457
19. Chembl149082
20. Nsc77071
21. Mfcd00008225
22. Tramiprosate (usan)
23. 3-aminopropane-1-sulfonic Acid (homotaurine)
24. C3h9no3s
25. 3-aminopropane-1-sulphonic Acid
26. 3-aminopropylsulfonic Acid
27. 3-aps
28. Nsc 77071
29. Einecs 222-977-4
30. 3-aminopropiosulfonic Acid
31. Tramiprosate [usan:inn]
32. Unii-5k8eax0g53
33. Ai3-52544
34. Nc-531
35. Aminopropanesulfonic-3
36. Acamprosate Impurity A
37. Spectrum_001340
38. Spectrum2_001409
39. Spectrum3_000924
40. Spectrum4_001023
41. Spectrum5_001319
42. Tramiprosate [mi]
43. Tramiprosate [inn]
44. Ec 222-977-4
45. Lopac0_000066
46. Schembl26759
47. 3-ammoniopropane-1-sulfonate
48. Kbiogr_001545
49. Kbioss_001820
50. Mls000028639
51. 3-aminopropane-1-sulfonicacid
52. Divk1c_000348
53. Spectrum1501125
54. Tramiprosate [who-dd]
55. Spbio_001458
56. 3-amino-1-propanesulphonic Acid
57. 3-amino-1-propane Sulfonic Acid
58. Hms501b10
59. Kbio1_000348
60. Kbio2_001820
61. Kbio2_004388
62. Kbio2_006956
63. Kbio3_001928
64. 3-amino-propane-1-sulfonic Acid
65. Dtxsid80190352
66. Ninds_000348
67. Hms1921h05
68. Hms2235l19
69. Hms3372l06
70. Amy23443
71. Zinc1529636
72. Bdbm50281573
73. Ccg-39012
74. Cpd-11725
75. S5131
76. Zinc01529636
77. Akos006221419
78. 3-amino-1-propanesulfonic Acid, 97%
79. Cs-5741
80. Db06527
81. Gs-3103
82. Idi1_000348
83. Ncgc00094904-01
84. Ncgc00094904-02
85. Hy-14602
86. Smr000059181
87. Sy006704
88. 3-aminopropane Sulfonic Acid [inci]
89. Db-049023
90. B7446
91. Ft-0614911
92. Acamprosate Related Compound A [usp-rs]
93. C03349
94. D06202
95. Ab00052207_13
96. 687h181
97. A823416
98. Acamprosate Calcium Impurity A [ep Impurity]
99. Q-200354
100. Q5891790
101. Acamprosate Impurity A, European Pharmacopoeia (ep) Reference Standard
102. Acamprosate Related Compound A, United States Pharmacopeia (usp) Reference Standard
103. A20
Molecular Weight | 139.18 g/mol |
---|---|
Molecular Formula | C3H9NO3S |
XLogP3 | -3.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 139.03031432 g/mol |
Monoisotopic Mass | 139.03031432 g/mol |
Topological Polar Surface Area | 88.8 Ų |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 133 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in strokes and alzheimer's disease.
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
GABA Agonists
Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA). (See all compounds classified as GABA Agonists.)
ABOUT THIS PAGE
A Homotaurine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Homotaurine, including repackagers and relabelers. The FDA regulates Homotaurine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Homotaurine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Homotaurine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Homotaurine supplier is an individual or a company that provides Homotaurine active pharmaceutical ingredient (API) or Homotaurine finished formulations upon request. The Homotaurine suppliers may include Homotaurine API manufacturers, exporters, distributors and traders.
click here to find a list of Homotaurine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Homotaurine DMF (Drug Master File) is a document detailing the whole manufacturing process of Homotaurine active pharmaceutical ingredient (API) in detail. Different forms of Homotaurine DMFs exist exist since differing nations have different regulations, such as Homotaurine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Homotaurine DMF submitted to regulatory agencies in the US is known as a USDMF. Homotaurine USDMF includes data on Homotaurine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Homotaurine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Homotaurine suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Homotaurine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Homotaurine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Homotaurine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Homotaurine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Homotaurine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Homotaurine suppliers with NDC on PharmaCompass.
Homotaurine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Homotaurine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Homotaurine GMP manufacturer or Homotaurine GMP API supplier for your needs.
A Homotaurine CoA (Certificate of Analysis) is a formal document that attests to Homotaurine's compliance with Homotaurine specifications and serves as a tool for batch-level quality control.
Homotaurine CoA mostly includes findings from lab analyses of a specific batch. For each Homotaurine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Homotaurine may be tested according to a variety of international standards, such as European Pharmacopoeia (Homotaurine EP), Homotaurine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Homotaurine USP).
LOOKING FOR A SUPPLIER?